Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare MC4R pathway diseases. The company is leveraging the Rhythm Engine -- comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program -- to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.RareObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information.
View Top Employees from Rhythm Pharmaceuticals Inc.Website | http://www.rhythmtx.com |
Ticker | RYTM |
Revenue | $4 million |
Funding | $598.5 million |
Employees | 253 (222 on RocketReach) |
Founded | 2008 |
Address | 222 Berkeley Street 12th Floor, Boston, Massachusetts 02116, US |
Phone | (857) 264-4280 |
Fax | (857) 264-4299 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
Keywords | Rare Disease, Biopharmaceuticals, Innovative Therapies, Drug Development And Manufacturing |
Competitors | Iveric Bio, An Astellas Company, Metacrine, Inc., Nabriva Therapeutics plc, PhaseBio Pharmaceuticals, Inc., Y-mAbs Therapeutics, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325413 Companies |
Looking for a particular Rhythm Pharmaceuticals Inc. employee's phone or email?
The Rhythm Pharmaceuticals Inc. annual revenue was $4 million in 2024.
Jennifer Chien is the Executive Vice President, Head of North America of Rhythm Pharmaceuticals Inc..
222 people are employed at Rhythm Pharmaceuticals Inc..
Rhythm Pharmaceuticals Inc. is based in Boston, Massachusetts.
The NAICS codes for Rhythm Pharmaceuticals Inc. are [3254, 325, 32541, 32, 325413].
The SIC codes for Rhythm Pharmaceuticals Inc. are [28, 283].